Search
Bluensomycin
go.drugbank.com/drugs/DB20923ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Bluensomycin is a antibiotic, produced by Streptomyces strain. Bluensomycin has a monoisotopic molecular weight of 585.25 Da.
Lydimycin
go.drugbank.com/drugs/DB21235ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Lydimycin is a antibiotic, produced by Streptomyces strain. Lydimycin has a monoisotopic molecular weight of 242.07 Da.
Amrinone
go.drugbank.com/drugs/DB01427ApprovedWithdrawnAmrinone (or inamrinone) is a type 3 pyridine phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure.
Aniline
go.drugbank.com/drugs/DB06728InvestigationalAniline is colorless, but it slowly oxidizes and resinifies in air, giving a red-brown tint to aged samples.
Synonyms: Trimethoprim specified impurity KAD 337
go.drugbank.com/drugs/DB05725InvestigationalThe drug was created by Sosei pharmaceuticals to treat Fibromyalgia in female patients.
GTP-506
go.drugbank.com/drugs/DB17682ExperimentalGTP-506 is a gene therapy formed by two vectors, a nuclease vector targeting gene editing in the well-characterized PCSK9 gene locus and a therapeutic donor vector that inserts the OTC gene to provide
Nitisinone
go.drugbank.com/drugs/DB00348ApprovedNitisinone is a synthetic reversible inhibitor of 4-hydroxyphenylpyruvate dioxygenase. It is used in the treatment of hereditary tyrosinemia type 1 and Alkaptonuria. It is sold under the brand names Orfadin and Harliku.
Tiaprofenic acid
go.drugbank.com/drugs/DB01600ApprovedTiaprofenic acid is a non-steroidal anti-inflammatory drug employed in the treatment of pain, particularly arthritis pain. It belongs to the arylpropionic acid (profen) group of nonsteroidal anti-inflammatory drugs (NSAIDs).
Davunetide
go.drugbank.com/drugs/DB12613InvestigationalDavunetide is the first drug to improve memory performance by impacting the mechanisms that lead to physical damage in the brain caused by neurofibrillary tangles, one of the two established pathological
CoronaVac
go.drugbank.com/drugs/DB15806InvestigationalIt was developed by propagating the SARS-CoV-2 CN2 strain inside Vero Cells and inactivating it with B-propiolactone[A219481;A219758]. … CoronaVac, previously known as PiCoVacc, is a SARS-CoV-2 purified, inactivated, and adsorbed vaccine candidate developed by SinoVac Biotech Corporation[A219758].